Skip to main content
Top
Published in: Supportive Care in Cancer 11/2005

01-11-2005 | Short Communication

Do cancer patients benefit from short-term contact with a general practitioner following cancer treatment? A randomised, controlled study

Authors: Knut Holtedahl, Jan Norum, Tor Anvik, Elin Richardsen

Published in: Supportive Care in Cancer | Issue 11/2005

Login to get access

Abstract

Goals of work

To investigate whether increased contact with the patient’s general practitioner (GP) soon after cancer treatment can increase patient quality of life (QoL) and satisfaction with follow-up.

Patients and methods

A randomised controlled study with 91 patients from one Norwegian municipality. The intervention group got a 30-min invited consultation with the patient’s GP and an invitation to further GP follow-up. Quality of life and patient satisfaction with diagnosis, treatment and overall care were measured with validated instruments.

Main results

Relatives’ satisfaction with care increased over 6 months in the intervention group (P=0.018), but otherwise, there was no difference between the intervention and control groups concerning QoL, satisfaction with care or number of consultations. Patient satisfaction with care showed a tendency to increase when treatment intent was curative. Some functional QoL measures and satisfaction tended to increase during the first 6 months after treatment. Free text comments suggested that some patients appreciated the contact with their GP.

Conclusion

Some cancer patients benefit from follow-up by their GP. The way to perform this kind of follow-up in primary care, and who these cancer patients are, should be further studied. Short follow-up time and an urban setting may have contributed to the lack of group differences in our study, but patients treated for cancer may have limited need for follow-up as long as they feel well and the situation remains stable.
Literature
1.
go back to reference Aaraas I, Førde OJ, Kristiansen IS, Melbye H (1998) Do general practitoner hospitals reduce the utilisation of general hospital beds? Evidence from Finnmark county in north Norway. J Epidemiol Community Health 52:243–246 Aaraas I, Førde OJ, Kristiansen IS, Melbye H (1998) Do general practitoner hospitals reduce the utilisation of general hospital beds? Evidence from Finnmark county in north Norway. J Epidemiol Community Health 52:243–246
2.
go back to reference Aaronson N, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez J et al. for the European Organisation for Research and Treatment of Cancer Study Group on Quality of Life et al (1993) The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 85:365–376 Aaronson N, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez J et al. for the European Organisation for Research and Treatment of Cancer Study Group on Quality of Life et al (1993) The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 85:365–376
3.
go back to reference Baker R, Preston C, Cheater F, Hearnshaw H (1999) Measuring patients’ attitudes to care across the primary/secondary interface: the development of the patient career diary. Qual Health Care 8:154–160 Baker R, Preston C, Cheater F, Hearnshaw H (1999) Measuring patients’ attitudes to care across the primary/secondary interface: the development of the patient career diary. Qual Health Care 8:154–160
4.
go back to reference Cheater FM, Preston C, Wynn A, Hearnshaw H, Baker R (1999) Patients’ views of cancer services: development of a questionnaire for accreditation. Eur J Oncol Nurs 3:72–82 Cheater FM, Preston C, Wynn A, Hearnshaw H, Baker R (1999) Patients’ views of cancer services: development of a questionnaire for accreditation. Eur J Oncol Nurs 3:72–82
5.
go back to reference Grunfeld E, Fitzpatrick R, Mant D, Yudkin P, Adewuyi-Dalton R, Stewart J, Cole D, Vessey M (1999) Comparison of breast cancer patient satisfaction with follow-up in primary care versus specialist care: results from a randomized controlled trial. Br J Gen Pract 49:705–710 Grunfeld E, Fitzpatrick R, Mant D, Yudkin P, Adewuyi-Dalton R, Stewart J, Cole D, Vessey M (1999) Comparison of breast cancer patient satisfaction with follow-up in primary care versus specialist care: results from a randomized controlled trial. Br J Gen Pract 49:705–710
6.
go back to reference Grunfeld E, Mant D, Yudkin P, Adewuyi-Dalton R, Cole D, Stewart J, Fitzpatrick R, Vessey M (1996) Routine follow-up of breast cancer in primary care: randomised trial. BMJ 313:665–669 Grunfeld E, Mant D, Yudkin P, Adewuyi-Dalton R, Cole D, Stewart J, Fitzpatrick R, Vessey M (1996) Routine follow-up of breast cancer in primary care: randomised trial. BMJ 313:665–669
7.
go back to reference Kattlove H, Winn RJ (2003) Ongoing care of patients after primary treatment for their cancer. CA Cancer J Clin 53:172–196 Kattlove H, Winn RJ (2003) Ongoing care of patients after primary treatment for their cancer. CA Cancer J Clin 53:172–196
8.
go back to reference Nielsen JD, Palshof T, Mainz J, Jensen AB, Olesen F (2003) Randomised controlled trial of a shared care programme for newly referred cancer patients: bridging the gap between general practice and hospital. Qual Saf Health Care 12:263–272 Nielsen JD, Palshof T, Mainz J, Jensen AB, Olesen F (2003) Randomised controlled trial of a shared care programme for newly referred cancer patients: bridging the gap between general practice and hospital. Qual Saf Health Care 12:263–272
9.
go back to reference Norman A, Sisler J, Hack T, Harlos M (2001) Family physicians and cancer care. Palliative care patients’ perspectives. Can Fam Physician 47:2009–2016 Norman A, Sisler J, Hack T, Harlos M (2001) Family physicians and cancer care. Palliative care patients’ perspectives. Can Fam Physician 47:2009–2016
10.
go back to reference Ringdal G, Ringdal K (1993) Testing the EORTC Quality of Life Questionnaire on cancer patients with heterogenous diagnoses. Qual Life Res 2:129–140 Ringdal G, Ringdal K (1993) Testing the EORTC Quality of Life Questionnaire on cancer patients with heterogenous diagnoses. Qual Life Res 2:129–140
11.
go back to reference Smith SM, Campbell NC (2004) Provision of oncology services in remote rural areas: a Scottish perspective. Eur J Cancer Care 13:185–192 Smith SM, Campbell NC (2004) Provision of oncology services in remote rural areas: a Scottish perspective. Eur J Cancer Care 13:185–192
12.
go back to reference Tattersall MHN, Thomas H (1999) Recent advances: oncology. BMJ 318:445–448 Tattersall MHN, Thomas H (1999) Recent advances: oncology. BMJ 318:445–448
13.
go back to reference Zitzelsberger L, Grunfeld E, Graham ID (2004) Family physicians’ perspectives on practice guidelines related to cancer control. BMC Fam Pract 5:25 Zitzelsberger L, Grunfeld E, Graham ID (2004) Family physicians’ perspectives on practice guidelines related to cancer control. BMC Fam Pract 5:25
Metadata
Title
Do cancer patients benefit from short-term contact with a general practitioner following cancer treatment? A randomised, controlled study
Authors
Knut Holtedahl
Jan Norum
Tor Anvik
Elin Richardsen
Publication date
01-11-2005
Publisher
Springer-Verlag
Published in
Supportive Care in Cancer / Issue 11/2005
Print ISSN: 0941-4355
Electronic ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-005-0869-5

Other articles of this Issue 11/2005

Supportive Care in Cancer 11/2005 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine